Application 210223
- Type
- ANDA
- Sponsor
- UBI
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | INJECTABLE;INJECTION | 0.004MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70860-454 | Desmopressin Acetate | desmopressin acetate | Athenex Pharmaceutical Division, LLC. | ANDA | Current |
| 70860-454 | Desmopressin Acetate | desmopressin acetate | Athenex Pharmaceutical Division, LLC. | ANDA | Current |
| 72843-440 | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | UBI Pharma Inc. | ANDA | Current |
| 72843-440 | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | UBI Pharma Inc. | ANDA | Current |
| 72843-440 | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | UBI Pharma Inc. | ANDA | Current |
| 72843-461 | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | UBI Pharma Inc. | ANDA | Current |
| 72843-461 | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | UBI Pharma Inc. | ANDA | Current |
| 72843-461 | DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | UBI Pharma Inc. | ANDA | Current |